Novartis pays $15M upfront to license Voyager program; Boehringer advances geographic atrophy drug

Plus, news about Jnana Therapeutics, Vaxcyte, C-Further, Genprex, PharmaEssentia, FORUS Therapeutics, Pharma Two B and Hepion:

Novartis licenses Voyager program: Voyager will get $15 million …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Beware of Fake Ozempic, FDA Warns

The FDA continues its investigation into counterfeit semaglutide (Ozempic) products — which may still be available for purchase — and has already seized thousands of

December 23, 2023

Immunotherapy Provided Clinical Benefit in Brain Metastases from Diverse Tumors

Credit: Alfred Pasieka/Science Photo LIB / Getty Images/Science Photo Libra Results from a Phase II clinical trial show immunotherapy with pembrolizumab provided a benefit in

June 7, 2023

NYU Langone Health performs the world’s first whole-eye and partial-face transplant for military veteran

A surgical team from NYU Langone Health performed the world’s first whole-eye and partial-face transplant for a 46-year-old military veteran from Arkansas who survived a

November 9, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.